Bodrozić, J.

Link to this page

Authority KeyName Variants
4a38e157-947b-4825-ad18-1710d29a4aec
  • Bodrozić, J. (5)
Projects

Author's Bibliography

Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism

Miljić, Predrag; Gvozdenov, Maja; Takagi, Y.; Takagi, A.; Pruner, Iva; Dragojević, M.; Tomić, Branko; Bodrozić, J.; Kojima, T.; Radojković, Dragica; Đorđević, Valentina

(Wiley, Hoboken, 2017)

TY  - JOUR
AU  - Miljić, Predrag
AU  - Gvozdenov, Maja
AU  - Takagi, Y.
AU  - Takagi, A.
AU  - Pruner, Iva
AU  - Dragojević, M.
AU  - Tomić, Branko
AU  - Bodrozić, J.
AU  - Kojima, T.
AU  - Radojković, Dragica
AU  - Đorđević, Valentina
PY  - 2017
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1045
AB  - Background: The recently reported c.1787G gt A mutation in the prothrombin gene leads to Arg596Gln replacement in the protein molecule (prothrombin Belgrade). This substitution impairs binding of antithrombin to thrombin and results in inherited thrombophilia, known as antithrombin resistance. Objectives: We aimed to elucidate the clinical and biochemical characteristics of thrombophilia associated with antithrombin resistance in a large Serbian family with the prothrombin Belgrade mutation. Patients and methods: Nineteen family members were investigated, among whom 10 were carriers of the c.1787G gt A mutation. In all subjects the clinical phenotype was determined and laboratory investigations of hemostatic parameters were performed. Results: Six out of the 10 mutation carriers developed thromboembolic events, mainly deep venous and mesenteric vein thrombosis. The median age of the first thrombotic event was 26.5 (12-41) years, whereas the incidence rate of first thrombosis was 2.2% per year. In all mutation carriers prothrombin activity was significantly decreased in comparison with non-carriers, clearly distinguishing each group. However, the presence of the mutation did not affect the prothrombin antigen level in plasma. The endogenous thrombin potential was significantly increased in all carriers in comparison with non-carriers, indicating the presence of blood hypercoagulability. Interestingly, levels of D-dimer and the F1+2 fragment were similar in both groups. Conclusions: Although rare, the prothrombin Belgrade mutation represents strong thrombophilia with early onset of thrombosis in the investigated family. According to our results, decreased prothrombin activity may be a simple screening test for detection of this mutation in thrombotic patients.
PB  - Wiley, Hoboken
T2  - Journal of Thrombosis and Haemostasis
T1  - Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism
EP  - 677
IS  - 4
SP  - 670
VL  - 15
DO  - 10.1111/jth.13618
ER  - 
@article{
author = "Miljić, Predrag and Gvozdenov, Maja and Takagi, Y. and Takagi, A. and Pruner, Iva and Dragojević, M. and Tomić, Branko and Bodrozić, J. and Kojima, T. and Radojković, Dragica and Đorđević, Valentina",
year = "2017",
abstract = "Background: The recently reported c.1787G gt A mutation in the prothrombin gene leads to Arg596Gln replacement in the protein molecule (prothrombin Belgrade). This substitution impairs binding of antithrombin to thrombin and results in inherited thrombophilia, known as antithrombin resistance. Objectives: We aimed to elucidate the clinical and biochemical characteristics of thrombophilia associated with antithrombin resistance in a large Serbian family with the prothrombin Belgrade mutation. Patients and methods: Nineteen family members were investigated, among whom 10 were carriers of the c.1787G gt A mutation. In all subjects the clinical phenotype was determined and laboratory investigations of hemostatic parameters were performed. Results: Six out of the 10 mutation carriers developed thromboembolic events, mainly deep venous and mesenteric vein thrombosis. The median age of the first thrombotic event was 26.5 (12-41) years, whereas the incidence rate of first thrombosis was 2.2% per year. In all mutation carriers prothrombin activity was significantly decreased in comparison with non-carriers, clearly distinguishing each group. However, the presence of the mutation did not affect the prothrombin antigen level in plasma. The endogenous thrombin potential was significantly increased in all carriers in comparison with non-carriers, indicating the presence of blood hypercoagulability. Interestingly, levels of D-dimer and the F1+2 fragment were similar in both groups. Conclusions: Although rare, the prothrombin Belgrade mutation represents strong thrombophilia with early onset of thrombosis in the investigated family. According to our results, decreased prothrombin activity may be a simple screening test for detection of this mutation in thrombotic patients.",
publisher = "Wiley, Hoboken",
journal = "Journal of Thrombosis and Haemostasis",
title = "Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism",
pages = "677-670",
number = "4",
volume = "15",
doi = "10.1111/jth.13618"
}
Miljić, P., Gvozdenov, M., Takagi, Y., Takagi, A., Pruner, I., Dragojević, M., Tomić, B., Bodrozić, J., Kojima, T., Radojković, D.,& Đorđević, V.. (2017). Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism. in Journal of Thrombosis and Haemostasis
Wiley, Hoboken., 15(4), 670-677.
https://doi.org/10.1111/jth.13618
Miljić P, Gvozdenov M, Takagi Y, Takagi A, Pruner I, Dragojević M, Tomić B, Bodrozić J, Kojima T, Radojković D, Đorđević V. Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism. in Journal of Thrombosis and Haemostasis. 2017;15(4):670-677.
doi:10.1111/jth.13618 .
Miljić, Predrag, Gvozdenov, Maja, Takagi, Y., Takagi, A., Pruner, Iva, Dragojević, M., Tomić, Branko, Bodrozić, J., Kojima, T., Radojković, Dragica, Đorđević, Valentina, "Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism" in Journal of Thrombosis and Haemostasis, 15, no. 4 (2017):670-677,
https://doi.org/10.1111/jth.13618 . .
16
6
16

Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis

Bodrozić, J.; Miljić, P.; Gojnić, M.; Vasić, D.; Đorđević, Valentina

(Wiley-Blackwell, Hoboken, 2016)

TY  - CONF
AU  - Bodrozić, J.
AU  - Miljić, P.
AU  - Gojnić, M.
AU  - Vasić, D.
AU  - Đorđević, Valentina
PY  - 2016
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/942
AB  - Background:Venous thromboembolism is one of the leading causes ofmaternal morbidity and mortality. The role of inherited thrombophiliain occurrence and localization of pregnancy related thrombosis is notclear.Aims:To investigate the influence of hereditary thrombophilia onlocalization and extent of thrombosis in women with thromboemboliccomplications during pregnancy and puerperium.Methods:We conducted a retrospective analysis of 212 consecutivewomen with pregnancy related deep vein thrombosis of lower extremi-ties (LE) or pulmonary embolism (PE) who were referred to our insti-tution for thrombophilia testing from January 2004 to December2015. When DVT of LE was present with PE, the event was accountedas PE. Thrombosis of superficial veins was excluded. All thromboticepisodes were confirmed with duplex ultrasonography and CT pneu-moangiography. In all women following causes of hereditary throm-bophilia were tested: factor V Leiden and prothrombin G20210Amutations, antithrombin, protein C and protein S deficiency. Bloodfor thrombophilia testing was obtained at least 3 months after cessa-tion of anticoagulant therapy.Results:Out of 212 women with pregnancy related thrombosis, 33(15,6%) developed PE, 73 (34,4%) developed unilateral thrombosis ofboth proximal and distal veins, 63 (29,7%) of proximal, and 36 (17%)of distal veins. Seven women (3,3%) developed concomitant bilateralthrombosis of deep veins of lower extremities. Hereditary throm-bophilia testing was positive in 82/212 (38,7%) women. Prevalence ofinherited thrombophilia was significantly higher in women with mas-sive DVT (proximal+distal veins) and in women with isolated DVT ofproximal veins than in women with PE and isolated DVT of distalveins.Conclusions:According to our results, inherited thrombophilia influ-ences localization and extent of pregnancy related thrombosis. Surpris-ingly, prevalence of thrombophilia was low in women who developedpregnancy related pulmonary embolism.
PB  - Wiley-Blackwell, Hoboken
C3  - Journal of Thrombosis and Haemostasis
T1  - Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis
EP  - 160
SP  - 160
VL  - 14
UR  - https://hdl.handle.net/21.15107/rcub_imagine_942
ER  - 
@conference{
author = "Bodrozić, J. and Miljić, P. and Gojnić, M. and Vasić, D. and Đorđević, Valentina",
year = "2016",
abstract = "Background:Venous thromboembolism is one of the leading causes ofmaternal morbidity and mortality. The role of inherited thrombophiliain occurrence and localization of pregnancy related thrombosis is notclear.Aims:To investigate the influence of hereditary thrombophilia onlocalization and extent of thrombosis in women with thromboemboliccomplications during pregnancy and puerperium.Methods:We conducted a retrospective analysis of 212 consecutivewomen with pregnancy related deep vein thrombosis of lower extremi-ties (LE) or pulmonary embolism (PE) who were referred to our insti-tution for thrombophilia testing from January 2004 to December2015. When DVT of LE was present with PE, the event was accountedas PE. Thrombosis of superficial veins was excluded. All thromboticepisodes were confirmed with duplex ultrasonography and CT pneu-moangiography. In all women following causes of hereditary throm-bophilia were tested: factor V Leiden and prothrombin G20210Amutations, antithrombin, protein C and protein S deficiency. Bloodfor thrombophilia testing was obtained at least 3 months after cessa-tion of anticoagulant therapy.Results:Out of 212 women with pregnancy related thrombosis, 33(15,6%) developed PE, 73 (34,4%) developed unilateral thrombosis ofboth proximal and distal veins, 63 (29,7%) of proximal, and 36 (17%)of distal veins. Seven women (3,3%) developed concomitant bilateralthrombosis of deep veins of lower extremities. Hereditary throm-bophilia testing was positive in 82/212 (38,7%) women. Prevalence ofinherited thrombophilia was significantly higher in women with mas-sive DVT (proximal+distal veins) and in women with isolated DVT ofproximal veins than in women with PE and isolated DVT of distalveins.Conclusions:According to our results, inherited thrombophilia influ-ences localization and extent of pregnancy related thrombosis. Surpris-ingly, prevalence of thrombophilia was low in women who developedpregnancy related pulmonary embolism.",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Journal of Thrombosis and Haemostasis",
title = "Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis",
pages = "160-160",
volume = "14",
url = "https://hdl.handle.net/21.15107/rcub_imagine_942"
}
Bodrozić, J., Miljić, P., Gojnić, M., Vasić, D.,& Đorđević, V.. (2016). Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis. in Journal of Thrombosis and Haemostasis
Wiley-Blackwell, Hoboken., 14, 160-160.
https://hdl.handle.net/21.15107/rcub_imagine_942
Bodrozić J, Miljić P, Gojnić M, Vasić D, Đorđević V. Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis. in Journal of Thrombosis and Haemostasis. 2016;14:160-160.
https://hdl.handle.net/21.15107/rcub_imagine_942 .
Bodrozić, J., Miljić, P., Gojnić, M., Vasić, D., Đorđević, Valentina, "Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis" in Journal of Thrombosis and Haemostasis, 14 (2016):160-160,
https://hdl.handle.net/21.15107/rcub_imagine_942 .

Antithrombin resistance caused by c.1787G gt a mutation in prothrombin gene: rare but strong inherited thrombophilia

Miljić, P.; Bodrozić, J.; Pruner, Iva; Đorđević, Valentina

(Wiley-Blackwell, Hoboken, 2016)

TY  - CONF
AU  - Miljić, P.
AU  - Bodrozić, J.
AU  - Pruner, Iva
AU  - Đorđević, Valentina
PY  - 2016
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/956
PB  - Wiley-Blackwell, Hoboken
C3  - Journal of Thrombosis and Haemostasis
T1  - Antithrombin resistance caused by c.1787G  gt  a mutation in prothrombin gene: rare but strong inherited thrombophilia
EP  - 97
SP  - 97
VL  - 14
UR  - https://hdl.handle.net/21.15107/rcub_imagine_956
ER  - 
@conference{
author = "Miljić, P. and Bodrozić, J. and Pruner, Iva and Đorđević, Valentina",
year = "2016",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Journal of Thrombosis and Haemostasis",
title = "Antithrombin resistance caused by c.1787G  gt  a mutation in prothrombin gene: rare but strong inherited thrombophilia",
pages = "97-97",
volume = "14",
url = "https://hdl.handle.net/21.15107/rcub_imagine_956"
}
Miljić, P., Bodrozić, J., Pruner, I.,& Đorđević, V.. (2016). Antithrombin resistance caused by c.1787G  gt  a mutation in prothrombin gene: rare but strong inherited thrombophilia. in Journal of Thrombosis and Haemostasis
Wiley-Blackwell, Hoboken., 14, 97-97.
https://hdl.handle.net/21.15107/rcub_imagine_956
Miljić P, Bodrozić J, Pruner I, Đorđević V. Antithrombin resistance caused by c.1787G  gt  a mutation in prothrombin gene: rare but strong inherited thrombophilia. in Journal of Thrombosis and Haemostasis. 2016;14:97-97.
https://hdl.handle.net/21.15107/rcub_imagine_956 .
Miljić, P., Bodrozić, J., Pruner, Iva, Đorđević, Valentina, "Antithrombin resistance caused by c.1787G  gt  a mutation in prothrombin gene: rare but strong inherited thrombophilia" in Journal of Thrombosis and Haemostasis, 14 (2016):97-97,
https://hdl.handle.net/21.15107/rcub_imagine_956 .

Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester

Bodrozić, J.; Miljić, Predrag; Gojnić, M.; Đorđević, Valentina

(Wiley-Blackwell, Hoboken, 2013)

TY  - CONF
AU  - Bodrozić, J.
AU  - Miljić, Predrag
AU  - Gojnić, M.
AU  - Đorđević, Valentina
PY  - 2013
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/634
PB  - Wiley-Blackwell, Hoboken
C3  - Journal of Thrombosis and Haemostasis
T1  - Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester
EP  - 868
SP  - 867
VL  - 11
UR  - https://hdl.handle.net/21.15107/rcub_imagine_634
ER  - 
@conference{
author = "Bodrozić, J. and Miljić, Predrag and Gojnić, M. and Đorđević, Valentina",
year = "2013",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Journal of Thrombosis and Haemostasis",
title = "Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester",
pages = "868-867",
volume = "11",
url = "https://hdl.handle.net/21.15107/rcub_imagine_634"
}
Bodrozić, J., Miljić, P., Gojnić, M.,& Đorđević, V.. (2013). Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester. in Journal of Thrombosis and Haemostasis
Wiley-Blackwell, Hoboken., 11, 867-868.
https://hdl.handle.net/21.15107/rcub_imagine_634
Bodrozić J, Miljić P, Gojnić M, Đorđević V. Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester. in Journal of Thrombosis and Haemostasis. 2013;11:867-868.
https://hdl.handle.net/21.15107/rcub_imagine_634 .
Bodrozić, J., Miljić, Predrag, Gojnić, M., Đorđević, Valentina, "Prevalence of hereditary thrombophilia is the highest in women who developed pregnancy related thrombosis during first trimester" in Journal of Thrombosis and Haemostasis, 11 (2013):867-868,
https://hdl.handle.net/21.15107/rcub_imagine_634 .

Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation

Miljić, Predrag; Bodrozić, J.; Đorđević, Valentina; Antović, Aleksandra

(Wiley-Blackwell, Hoboken, 2013)

TY  - CONF
AU  - Miljić, Predrag
AU  - Bodrozić, J.
AU  - Đorđević, Valentina
AU  - Antović, Aleksandra
PY  - 2013
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/635
PB  - Wiley-Blackwell, Hoboken
C3  - Journal of Thrombosis and Haemostasis
T1  - Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation
EP  - 1014
SP  - 1013
VL  - 11
UR  - https://hdl.handle.net/21.15107/rcub_imagine_635
ER  - 
@conference{
author = "Miljić, Predrag and Bodrozić, J. and Đorđević, Valentina and Antović, Aleksandra",
year = "2013",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Journal of Thrombosis and Haemostasis",
title = "Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation",
pages = "1014-1013",
volume = "11",
url = "https://hdl.handle.net/21.15107/rcub_imagine_635"
}
Miljić, P., Bodrozić, J., Đorđević, V.,& Antović, A.. (2013). Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation. in Journal of Thrombosis and Haemostasis
Wiley-Blackwell, Hoboken., 11, 1013-1014.
https://hdl.handle.net/21.15107/rcub_imagine_635
Miljić P, Bodrozić J, Đorđević V, Antović A. Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation. in Journal of Thrombosis and Haemostasis. 2013;11:1013-1014.
https://hdl.handle.net/21.15107/rcub_imagine_635 .
Miljić, Predrag, Bodrozić, J., Đorđević, Valentina, Antović, Aleksandra, "Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation" in Journal of Thrombosis and Haemostasis, 11 (2013):1013-1014,
https://hdl.handle.net/21.15107/rcub_imagine_635 .